Long-term complete response of early gastric cancer to nivolumab: report of a case with disease-free survival for six years
{{output}}
Although immune checkpoint inhibitors have demonstrated efficacy in advanced gastric cancer, reports of long-term complete remission in early-stage disease are lacking. We report a case of a 75-year-old man who presented with concurrent malignant melanoma and ... ...
